Latest filing published 03 Sept 2026 for Neogenomics INC.
Alicia C. Olivo is a declared insider of Neogenomics Inc (senior executive), with filings sourced from SEC (Form 4). We count 25 filings; the first trade dates from 1 May 2023 and the latest from 1 September 2026.
Every open-market trade on record is a sale: 6 sales worth €229k. Besides market trades, the filings include 11 share grants and 8 option exercises.
The latest filing, published on 3 September 2026, reports a share grant in Neogenomics Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 25 declarations